DISCOVER OUR NEWS
TheraPPI Bioscience awarded a Fongit Innovation Fund (FIF) seed loan
The Fondation Genevoise pour l’Innovation Technologique has granted a FIF seed loan of CHF100 000 to TheraPPI
TheraPPI Bioscience announces an exclusive license agreement with PULSALYS to develop novel drugs in oncology and rare diseases
PULSALYS and TheraPPI Bioscience SAS enter into an exclusive and global license agreement to develop drugs targeting a novel Ras-MAPK pathway protein interaction